大流行对美国非covid -19死亡原因的影响:多原因死亡分析

IF 7.7 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Yu Li, Hang Li, Tim Adair
{"title":"大流行对美国非covid -19死亡原因的影响:多原因死亡分析","authors":"Yu Li, Hang Li, Tim Adair","doi":"10.1007/s10654-025-01214-z","DOIUrl":null,"url":null,"abstract":"<p>Multiple cause of death data allow for a more granular analysis of the pandemic’s impact on mortality from non-COVID-19 causes of death compared with analysis of a single underlying cause of each death because they are often a co-morbidity of COVID-19. This study estimates excess mortality in the US of non-COVID-19 causes measured as a multiple cause (reported anywhere on the death certificate). Death registration data were used to conduct Poisson regressions of 24 non-COVID-19 causes to estimate expected age-standardized death rates and excess mortality in 2020–21, including by place of death. The ratio of COVID-19 mortality (as underlying or contributing cause) to excess mortality of each non-COVID-19 cause was calculated. During 2020–21, 21 of 24 non-COVID-19 causes exhibited excess mortality, highest for pneumonia (males 126.5%; 95% confidence interval 116.6–136.9%), other respiratory diseases (males 45.2%; 42.2–48.2%), other kidney diseases (males 45.0%, 37.8–52.0%), diabetes (females 38.3%, 32.8–43.4%) and hypertensive heart disease (females 28.9%, 22.8–33.9%). Suicide and influenza mortality was lower than expected. The ratio of COVID-19 (underlying cause) to excess mortality was 74.2% (69.2–79.7%) for men and 68.7% (63.5–75.0%) for women, was significantly higher for hospital (over 90%) than home (less than 16%) deaths and varied greatly between causes. The pandemic led to excess mortality for almost all non-COVID-19 causes in the US when measured as a multiple cause, being particularly high in several non-communicable diseases that increase the risk of dying from COVID-19. COVID-19 appears underreported for home deaths due to its low ratio to excess mortality in this setting.</p>","PeriodicalId":11907,"journal":{"name":"European Journal of Epidemiology","volume":"183 1","pages":""},"PeriodicalIF":7.7000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The impact of the pandemic on non-COVID-19 causes of death in the United States: a multiple cause of death analysis\",\"authors\":\"Yu Li, Hang Li, Tim Adair\",\"doi\":\"10.1007/s10654-025-01214-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Multiple cause of death data allow for a more granular analysis of the pandemic’s impact on mortality from non-COVID-19 causes of death compared with analysis of a single underlying cause of each death because they are often a co-morbidity of COVID-19. This study estimates excess mortality in the US of non-COVID-19 causes measured as a multiple cause (reported anywhere on the death certificate). Death registration data were used to conduct Poisson regressions of 24 non-COVID-19 causes to estimate expected age-standardized death rates and excess mortality in 2020–21, including by place of death. The ratio of COVID-19 mortality (as underlying or contributing cause) to excess mortality of each non-COVID-19 cause was calculated. During 2020–21, 21 of 24 non-COVID-19 causes exhibited excess mortality, highest for pneumonia (males 126.5%; 95% confidence interval 116.6–136.9%), other respiratory diseases (males 45.2%; 42.2–48.2%), other kidney diseases (males 45.0%, 37.8–52.0%), diabetes (females 38.3%, 32.8–43.4%) and hypertensive heart disease (females 28.9%, 22.8–33.9%). Suicide and influenza mortality was lower than expected. The ratio of COVID-19 (underlying cause) to excess mortality was 74.2% (69.2–79.7%) for men and 68.7% (63.5–75.0%) for women, was significantly higher for hospital (over 90%) than home (less than 16%) deaths and varied greatly between causes. The pandemic led to excess mortality for almost all non-COVID-19 causes in the US when measured as a multiple cause, being particularly high in several non-communicable diseases that increase the risk of dying from COVID-19. COVID-19 appears underreported for home deaths due to its low ratio to excess mortality in this setting.</p>\",\"PeriodicalId\":11907,\"journal\":{\"name\":\"European Journal of Epidemiology\",\"volume\":\"183 1\",\"pages\":\"\"},\"PeriodicalIF\":7.7000,\"publicationDate\":\"2025-03-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10654-025-01214-z\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10654-025-01214-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

与分析每种死亡的单一根本原因相比,多种死亡原因数据可以更细致地分析大流行对非COVID-19死亡原因造成的死亡率的影响,因为它们往往是COVID-19的合并症。这项研究估计了美国非covid -19原因的超额死亡率,以多种原因衡量(在死亡证明的任何地方报告)。使用死亡登记数据对24种非covid -19病因进行泊松回归,以估计2020-21年的预期年龄标准化死亡率和超额死亡率,包括按死亡地点分列的死亡率。计算了COVID-19死亡率(作为潜在或促成原因)与每种非COVID-19原因的超额死亡率的比率。在2020 - 2021年期间,24种非covid -19病因中有21种表现出过高的死亡率,其中肺炎死亡率最高(男性126.5%;95%可信区间116.6-136.9%),其他呼吸道疾病(男性45.2%;42.2-48.2%),其他肾脏疾病(男性45.0%,37.8-52.0%),糖尿病(女性38.3%,32.8-43.4%)和高血压心脏病(女性28.9%,22.8-33.9%)。自杀和流感死亡率低于预期。COVID-19(根本原因)与超额死亡率之比,男性为74.2%(69.2-79.7%),女性为68.7%(63.5-75.0%),医院死亡(超过90%)明显高于家庭死亡(低于16%),不同原因之间差异很大。当作为多原因衡量时,大流行导致美国几乎所有非COVID-19原因的死亡率过高,在几种增加COVID-19死亡风险的非传染性疾病中死亡率尤其高。由于在这种情况下COVID-19与超额死亡率的比例较低,因此家中死亡人数似乎被低估了。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The impact of the pandemic on non-COVID-19 causes of death in the United States: a multiple cause of death analysis

Multiple cause of death data allow for a more granular analysis of the pandemic’s impact on mortality from non-COVID-19 causes of death compared with analysis of a single underlying cause of each death because they are often a co-morbidity of COVID-19. This study estimates excess mortality in the US of non-COVID-19 causes measured as a multiple cause (reported anywhere on the death certificate). Death registration data were used to conduct Poisson regressions of 24 non-COVID-19 causes to estimate expected age-standardized death rates and excess mortality in 2020–21, including by place of death. The ratio of COVID-19 mortality (as underlying or contributing cause) to excess mortality of each non-COVID-19 cause was calculated. During 2020–21, 21 of 24 non-COVID-19 causes exhibited excess mortality, highest for pneumonia (males 126.5%; 95% confidence interval 116.6–136.9%), other respiratory diseases (males 45.2%; 42.2–48.2%), other kidney diseases (males 45.0%, 37.8–52.0%), diabetes (females 38.3%, 32.8–43.4%) and hypertensive heart disease (females 28.9%, 22.8–33.9%). Suicide and influenza mortality was lower than expected. The ratio of COVID-19 (underlying cause) to excess mortality was 74.2% (69.2–79.7%) for men and 68.7% (63.5–75.0%) for women, was significantly higher for hospital (over 90%) than home (less than 16%) deaths and varied greatly between causes. The pandemic led to excess mortality for almost all non-COVID-19 causes in the US when measured as a multiple cause, being particularly high in several non-communicable diseases that increase the risk of dying from COVID-19. COVID-19 appears underreported for home deaths due to its low ratio to excess mortality in this setting.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Journal of Epidemiology
European Journal of Epidemiology 医学-公共卫生、环境卫生与职业卫生
CiteScore
21.40
自引率
1.50%
发文量
109
审稿时长
6-12 weeks
期刊介绍: The European Journal of Epidemiology, established in 1985, is a peer-reviewed publication that provides a platform for discussions on epidemiology in its broadest sense. It covers various aspects of epidemiologic research and statistical methods. The journal facilitates communication between researchers, educators, and practitioners in epidemiology, including those in clinical and community medicine. Contributions from diverse fields such as public health, preventive medicine, clinical medicine, health economics, and computational biology and data science, in relation to health and disease, are encouraged. While accepting submissions from all over the world, the journal particularly emphasizes European topics relevant to epidemiology. The published articles consist of empirical research findings, developments in methodology, and opinion pieces.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信